Longevity Biotech to Participate in Longevity Therapeutics Conference

Longevity Therapeutics Conference

January 28th, 2021Longevity Biotech to Participate in Longevity Therapeutics Conference Longevity Biotech CEO, Dr. Scott Shandler, Ph.D., will participate in the 3rd annual Longevity Therapeutics Conference held on January 27-28th, 2021.  Dr. Shandler will participate … Read More

Biomarkers for AD Conference

Longevity Biotech CEO Scott Shandler to share precision neuroscience insights and lessons learned from recent Parkinson’s Disease biomarker study.